Ertapenem for Infections Caused by ESBL-producing Bacteria: Discussion – Medscape News

Importantly, these data suggest that treatment with ertapenem is associated with good clinical and microbiologic outcomes that are very similar to those achieved with group 2 carbapenems as described in prior literature. [3–5] Previous studies suggested …

Leave a Reply

Your email address will not be published. Required fields are marked *